ChemoCentryx
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of ChemoCentryx generated cash of -$75,621,000, which is more than the previous year. Cash used in financing activities reached the amount of $1,083,000 last year. Net change in cash is therefore $17,681,000.
Cash Flow
| 2012 | -32.22M | -56.90M | 57.43M |
|---|---|---|---|
| 2013 | -33.31M | -31.66M | 66.78M |
| 2014 | -34.31M | 38.33M | 1.79M |
| 2015 | -39.32M | 33.88M | 2.19M |
| 2016 | 39.14M | -48.76M | 8.82M |
| 2017 | 4.87M | 15.60M | 7.51M |
| 2018 | 16.43M | -53.06M | 24.7M |
| 2019 | -70.12M | -12.52M | 94.82M |
| 2020 | -81.14M | -282.36M | 356.62M |
| 2021 | -75.62M | 92.21M | 1.08M |
CCXI Cash Flow Statement (2012 – 2021)
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 33.37M | 40.25M | 28.08M | 40.02M | 12.02M | 12.82M | 16.07M | 10.25M | 8.46M | 40.15M |
Operating activities | ||||||||||
Net income | -131.75M | -55.35M | -55.48M | -37.96M | 17.85M | -39.96M | -47.30M | -46.92M | -38.67M | -39.89M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.13M | 797K | 1.64M | 512K | 418K | 348K | 477K | 543K | 576K | 592K |
Stock-based compensation expense | 30.69M | 22.91M | 11.63M | 10.83M | 8.74M | 8.53M | 8.98M | 8.21M | 6.24M | 4.95M |
| Deferred income tax benefit | 30.69M | 22.91M | 11.63M | 10.83M | 8.74M | 8.53M | 8.98M | 8.21M | 6.24M | 4.95M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -274K | 7K | 1.88M | 49.03M | -20.88M | -30.20M | 0 | 393K | 763K | -649K |
Inventories | -851K | 8.30M | 5.23M | 3.45M | -727K | 3.68M | 0 | 1.48M | -689K | 0 |
Accounts payable | 2.61M | 2.98M | 188K | -434K | 729K | -4K | -73K | -161K | 159K | 214K |
Cash generated by operating activities | -75.62M | -81.14M | -70.12M | 16.43M | 4.87M | 39.14M | -39.32M | -34.31M | -33.31M | -32.22M |
Investing activities | ||||||||||
Purchases Of Investments | -307.44M | -445.67M | -211.97M | -192.48M | -133.84M | -136.23M | -24.37M | -100.83M | -136.6M | -177.56M |
Investments In Property Plant And Equipment | -19.02M | -15.40M | -790K | -838K | -723K | -304K | -218K | -352K | -554K | -472K |
Acquisitions Net | -92.21M | 0 | 0 | 0 | 0 | 0 | -33.88M | -38.33M | 31.66M | 0 |
Cash generated by investing activities | 92.21M | -282.36M | -12.52M | -53.06M | 15.60M | -48.76M | 33.88M | 38.33M | -31.66M | -56.90M |
Financing activities | ||||||||||
Common Stock Issued | 7.40M | 325.65M | 73.27M | 0 | 0 | 7M | 0 | 0 | 64.36M | 57.01M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -1.04M | 0 | 0 | 0 | 0 | 0 | 0 | -330K | -571K | -547K |
Cash used in financing activities | 1.08M | 356.62M | 94.82M | 24.7M | 7.51M | 8.82M | 2.19M | 1.79M | 66.78M | 57.43M |
Net Change In Cash | 17.68M | -6.88M | 12.17M | -11.93M | 27.99M | -799K | -3.25M | 5.81M | 1.79M | -31.69M |
Cash at end of period | 51.05M | 33.37M | 40.25M | 28.08M | 40.02M | 12.02M | 12.82M | 16.07M | 10.25M | 8.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |